GlassScriptPhysician profile
Bhavani Rao
NPI 1790887909
$2,040.36
in general payments reported to CMS, 2019-2025
18 companies · $704 in 2025
The $704 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.37 · 2020: $13.06 · 2021: $60.33 · 2022: $158 · 2023: $478 · 2024: $558 · 2025: $704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,705 · Education: $33.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,705.20 |
| Education | $33.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $472.09 | 2023-2025 | Purified Cortrophin Gel |
| Astrazeneca Pharmaceuticals LP | $342.93 | 2019-2024 | Farxiga, Lokelma |
| Bayer Healthcare Pharmaceuticals INC. | $305.78 | 2024-2025 | |
| Viatris Specialty LLC | $250.00 | 2025 | Yupelri |
| Mallinckrodt Hospital Products INC. | $184.30 | 2022-2025 | Acthar |
| Calliditas Therapeutics US INC. | $121.47 | 2023-2025 | Tarpeyo |
| Novo Nordisk INC | $81.21 | 2019-2024 | Wegovy |
| Otsuka America Pharmaceutical, INC. | $69.34 | 2021-2025 | Jynarque |
| Renalytix Ai, INC. | $43.92 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Daiichi Sankyo INC. | $31.46 | 2019-2023 | Injectafer |
| Novartis Pharmaceuticals Corporation | $30.31 | 2024 | |
| Lilly USA, LLC | $27.04 | 2019-2025 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.60 | 2019 | |
| Amgen INC. | $13.87 | 2021 | |
| Glaxosmithkline, LLC. | $13.73 | 2023 | Benlysta |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $13.64 | 2022 | |
| Abbvie INC. | $13.06 | 2020 | |
| Abbott Laboratories | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhavani Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.